1) Develop and market " Molecular Imaging Agent of Oxygen Metabolism for Realtime Non-Invasive InViVo Monitoring ", at the cellular level, with a resolution of 1 mm, using a standard Magentic Resonance Imager, of biological subjects. 2) Oxy-17® is our " Contrast Media " product line for either Inhalation or as an injectable ( IV) & (IA) applications. 3) OxyMaps™ is software giving pictorial rendering in 2D & 3D showing Tissue with different Oxygen Uptake Rate Zones in the context of its surrounding anatomy. Oxy-17® and OxyMaps™ are useful as " Non Invasive Realtime Tissue Stress Monitor" to evaluate normal and abnormal Oxygen Consumption rates in a biological subject, without any limitations on repeating the test due to dosage and/or other limitations. This is Platform Technology for "InViVo Realtime Tissue Viability Imaging" and is protected by issued and registered Intellectual Property in 95% of the world markets for MRI Imaging. The company has the worlds largest production souce of materials secured that comprises Oxy-17® , for medical Imaging.